» Articles » PMID: 31504404

Temporal Trends in Bleeding Events in Acute Myocardial Infarction: Insights from the SWEDEHEART Registry

Abstract

Aims: To describe the time trends of in-hospital and out-of-hospital bleeding parallel to the development of new treatments and ischaemic outcomes over the last 20 years in a nationwide myocardial infarction (MI) population.

Methods And Results: Patients with acute MI (n = 371 431) enrolled in the SWEDEHEART registry from 1995 until May 2018 were selected and evaluated for in-hospital bleeding and out-of-hospital bleeding events at 1 year. In-hospital bleeding increased from 0.5% to a peak at 2% 2005/2006 and thereafter slightly decreased to a new plateau around 1.3% by the end of the study period. Out-of-hospital bleeding increased in a stepwise fashion from 2.5% to 3.5 % in the middle of the study period and to 4.8% at the end of the study period. The increase in both in-hospital and out-of-hospital bleeding was parallel to increasing use of invasive strategy and adjunctive antithrombotic treatment, dual antiplatelet therapy (DAPT), and potent DAPT, while the decrease in in-hospital bleeding from 2007 to 2010 was parallel to implementation of bleeding avoidance strategies. In-hospital re-infarction decreased from 2.8% to 0.6% and out-of-hospital MI decreased from 12.6% to 7.1%. The composite out-of-hospital MI, cardiovascular death, and stroke decreased in a similar fashion from 18.4% to 9.1%.

Conclusion: During the last 20 years, the introduction of invasive and more intense antithrombotic treatment has been associated with an increase in bleeding events but concomitant there has been a substantial greater reduction of ischaemic events including improved survival.

Citing Articles

Clinical Review of Cardiogenic Shock After Acute Myocardial Infarction - Revascularization, Mechanical Circulatory Support, and Beyond.

Saito Y, Tateishi K, Kobayashi Y Circ Rep. 2025; 7(1):6-14.

PMID: 39802125 PMC: 11711789. DOI: 10.1253/circrep.CR-24-0141.


Self-administration of aspirin for acute chest pain-Does it prevent premature cardiovascular mortality?.

Lamm G Wien Klin Wochenschr. 2024; .

PMID: 39688630 DOI: 10.1007/s00508-024-02471-w.


Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review.

Saito Y, Kobayashi Y J Arrhythm. 2024; 40(5):1108-1114.

PMID: 39416245 PMC: 11474516. DOI: 10.1002/joa3.13128.


Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention.

Galli M, Laborante R, Andreotti F, Vergallo R, Montone R, Iaconelli A Rev Cardiovasc Med. 2024; 23(8):286.

PMID: 39076646 PMC: 11266963. DOI: 10.31083/j.rcm2308286.


Diagnostic ability of Japanese version of high bleeding risk criteria for ischemic outcomes in patients with acute myocardial infarction.

Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K Heart Vessels. 2023; 39(1):1-9.

PMID: 37598361 DOI: 10.1007/s00380-023-02303-3.